Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Lovastatin 💬

[1] HMGCR 💬

[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬

[11] 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬

Disease ID	Name
6	Parkinson disease
34	Neurofibromatosis
46	Malignant rheumatoid arthritis
79	Homozygous familial hypercholesterolemia
156	Rett syndrome
160	Congenital ichthyosis
195	Noonan syndrome
206	Fragile X syndrome
263	Cerebrotendinous xanthomatosis
280	Huge arteriovenous malformation with cervicofacial or limb lesion
310	Congenital anomalies syndrome

2

Lovastatin 60 MG

[1] Lovastatin 💬

[1] HMGCR 💬

[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬

[1] 34 💬

3

[1] Lovastatin 💬

[1] HMGCR 💬

[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬

[1] 34 💬

4

Lovastatin, then Minocycline/Lovastatin

[2] Lovastatin,
Minocycline

[2] Lovastatin ,
Minocycline 💬

[1] HMGCR 💬

[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬

[1] 206 💬

5

Minocycline, then Minocycline/Lovastatin

[2] Lovastatin,
Minocycline

[2] Lovastatin ,
Minocycline 💬

[1] HMGCR 💬

[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬

[1] 206 💬